PVR and colorectal cancer: On the contrary, the same authors demonstrated that knocking out CD155 in colorectal cancer cells promotes the effector function of tumor-infiltrating CD8+ T cells, and inhibition of the CD155–TIGIT pathway suppresses the tumor growth in an in vivo mouse model.